A double-blind study evaluating the efficacy and safety of the combination of etanercept and methotrexate in comparison to etanercept alone or methotrexate alone in rheumatoid arthritis patients.

Trial Profile

A double-blind study evaluating the efficacy and safety of the combination of etanercept and methotrexate in comparison to etanercept alone or methotrexate alone in rheumatoid arthritis patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 May 2014

At a glance

  • Drugs Etanercept; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TEMPO
  • Sponsors Wyeth
  • Most Recent Events

    • 01 May 2014 Results from a pooled analysis published in the Clinical and Experimental Rheumatology.
    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top